줄기세포의 국내외 임상 적용 동향

• 영문명: The trend of clinical applications of stem cells
• 발행기관: 이화여자대학교 생명의료법연구소
• 저자명: 김명희(Myung-Hee KIM)
• 간행물 정보: 『생명윤리정책연구(제 9권 제 3호 이전)』제1권 제1호, 39~49쪽, 전체 11쪽
• 주제분류: 법학 > 법학
• 파일형태: PDF
• 발행일자: 2007.08.30

영문 초록

Many people thought stem cells are used for various of kinds of diseases prior to Dr. Hwang’s Scandal. However, clinical application of stem cells for patients is not easy as people would think, because the knowledge and information of stem cells are not well known still. There are about 200 clinical applied cases from 2004. There have been many problems of clinical applications of stem cells in Korea. The applied stem cells are almost adult stem cells that delivered from cord blood or patient body himself. The clinical practices of stem cells have been conducted under the name of ‘Emergency Clinical Trials’ without proper clinical trial results or evidence based positive clinical results. Many patients paid a huge amount of money for practices that were not proved and it became a social issue. The KFDA were involved and changed the guideline in order to solve the problems of emergency clinical trials. There are many kinds of stem cell clinical trials in the world and most of them are adult stem cell cases. Currently a limited number of countries have special guidelines for stem cell clinical trials and most of other countries do not have them. This related to why the information and knowledge of stem cells are still not well known. We have to be careful with clinical use of stem cells even adult stem cells. We have to strictly follow the general guideline of clinical trials and make further specified guidelines to prevent complications and problems using stem cells for clinical applications.

목차

I. 시작하며

II. 국내 동향

III. 국외 동향

IV. 각국의 정책

V. 맺으면서

키워드

줄기세포(stem cell) 임상적용(clinical application) 줄기세포 임상시험(clinical trial of stem cells), 임상시험지침(guideline of clinical trial)